首页> 美国卫生研究院文献>The Journal of Headache and Pain >Changes in calcitonin gene-related peptide (CGRP) receptor component and nitric oxide receptor (sGC) immunoreactivity in rat trigeminal ganglion following glyceroltrinitrate pretreatment
【2h】

Changes in calcitonin gene-related peptide (CGRP) receptor component and nitric oxide receptor (sGC) immunoreactivity in rat trigeminal ganglion following glyceroltrinitrate pretreatment

机译:硝酸甘油预处理后大鼠三叉神经节降钙素基因相关肽(CGRP)受体成分和一氧化氮受体(sGC)免疫反应性的变化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundNitric oxide (NO) is thought to play an important role in the pathophysiology of migraine. Infusion of the nitrovasodilator glyceroltrinitrate (nitroglycerin, GTN), which mobilizes NO in the organism, is an approved migraine model in humans. Calcitonin gene-related peptide (CGRP) is regarded as another key mediator in migraine. Increased plasma levels of CGRP have been found during spontaneous as well as nitrovasodilator-induced migraine attacks. The nociceptive processes and interactions underlying the NO and CGRP mediated headache are poorly known but can be examined in animal experiments. In the present study we examined changes in immunofluorescence of CGRP receptor components (CLR and RAMP1) and soluble guanylyl cyclase (sGC), the intracellular receptor for NO, in rat trigeminal ganglia after pretreatment with GTN.
机译:背景一氧化氮(NO)被认为在偏头痛的病理生理中起重要作用。硝化血管扩张剂硝化甘油三硝酸酯(硝酸甘油,GTN)的动员生物体中的NO是人类公认的偏头痛模型。降钙素基因相关肽(CGRP)被认为是偏头痛的另一种关键介质。在自发以及硝化舒张药引起的偏头痛发作期间,已发现血浆CGRP水平升高。 NO和CGRP介导的头痛的伤害感受过程和相互作用尚不清楚,但可以在动物实验中进行检查。在本研究中,我们检查了GTN预处理后大鼠三叉神经节中CGRP受体组分(CLR和RAMP1)和可溶性鸟苷基环化酶(sGC)(NO的细胞内受体)的免疫荧光变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号